Latest Boardroom Shifts News

Clover Corporation Limited reported a standout FY25 with robust revenue growth and a sharp rise in profitability, underpinned by strategic market expansion and product innovation. The company’s strengthened balance sheet and optimistic FY26 outlook signal continued momentum.

Aspermont Limited’s shares have been suspended from trading due to a critical shortfall in board directors, raising questions about its governance and future compliance.

Middle Island Resources announces the immediate resignation of CEO Roland Bartsch, with the company opting to pay out his full notice period and his unlisted options lapsing as per contract terms.

James Hardie Industries has appointed Ryan Lada as its new Chief Financial Officer, succeeding Rachel Wilson who will remain as an advisor during the transition. The move comes alongside the company’s Q2 FY26 results announcement.

L1 Group Limited has completed its transformative merger between Platinum Asset Management and L1 Capital, creating a $16.7 billion funds under management powerhouse, backed by a $286 million capital raise to fuel growth.

James Hardie Industries has appointed Nigel Stein as the new Chair of its Board and established an Integration and Performance Committee to oversee the AZEK acquisition integration and enhance shareholder engagement.

Dalaroo Metals has appointed seasoned mining executive John Morgan as CEO, signaling a strategic push to advance its exploration projects across multiple continents. His performance-linked incentives align leadership rewards with shareholder value creation.

ALS Limited has reported a robust first half for FY26, with revenue climbing 13.3% to $1.7 billion and underlying NPAT rising 17.2%, driven by strong organic growth across all business streams and strategic investments in digital innovation.

ALS Limited has posted a robust first half for FY26 with underlying EBIT growth of 14.7%, driven by strong performance in its Commodities segment and improved Life Sciences results. The company also raised its interim dividend and updated its growth outlook for the year.

Shriro Holdings reported a 13.6% revenue decline in FY25 amid a strategic shift in its BBQ segment but delivered a 5.5% rise in EBITDA. The company plans a $20 million share buy-back in FY26, signaling confidence in its operational turnaround.

Argent BioPharma has locked in an A$11 million convertible financing facility to finalize its strategic acquisition of AusCann assets and accelerate its growth plans, including a potential US stock exchange listing.

Diablo Resources has appointed Matthew Blumberg as a Non-Executive Director and brought on Ellis Martin as its U.S. Media and Investor Communications Advisor, signaling a strategic push into North American markets.